GRAIL Q4 rev $38.3M (+26%), net loss $97.1M; FY Galleri rev $108.6M (+45%); adds TRICARE coverage

GRAIL, Inc.

2024-FY EPS reported -$63.54 revenue$125,595,000

Q4 total revenue $38.3M (+26% YoY); Q4 Galleri revenue $31.6M (+39% YoY).
Full year 2024 total revenue $125.6M (+35% YoY); Galleri revenue $108.6M (+45% YoY).
Q4 net loss $97.1M including $34.6M amortization; full year net loss $2.0B incl $1.4B goodwill impairment.
Non-GAAP adjusted EBITDA: Q4 ($84.0M), full year ($483.5M); cash position $767M, runway into 2028.
TRICARE added Galleri as covered benefit for 50+ patients; registrational studies completed, PMA submission planned H1 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.